Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Blood Advances|February 15, 2024
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 24, 2022
Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination EraCeline M Vachon, Aaron D Norman, Kavita Prasad, et al.International Journal of Molecular Sciences|May 13, 2023
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Rob Ter Horst, et al.Journal of the National Cancer Institute. Monographs|September 1, 2014
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Joshua N Sampson, James R Cerhan, et al.Blood|April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.Blood Advances|September 3, 2025
Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemiaAntonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Juan José Rodríguez-Sevilla, et al.International Journal of Cancer|March 6, 2021
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patientsAngelica Macauda, Chiara Piredda, Alyssa I Clay-Gilmour, et al.International Journal of Cancer|March 11, 2026
ULK4 and CDKN2A polymorphisms influence the risk of developing monoclonal gammopathy of undetermined significanceJosé Manuel Sánchez-Maldonado, Angelica Macauda, Antonio José Cabrera-Serrano, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 14, 2022
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?Angelica Macauda, Alyssa Clay-Gilmour, Thomas Hielscher, et al.International Journal of Cancer|September 9, 2022
A pleiotropic variant in DNAJB4 is associated with multiple myeloma riskMarco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, et al.Pageof 6